It is well known that MSC-Exos–sourced IL-10 induces the development of tolerogenic DCs, which then interact with naïve CD4+T cells to drive their differentiation into FoxP3+Tregs, fostering an immunosuppressive environment in the inflamed eyes of pSS patients [25, 26]. Here, FOXP3 is linked to peeling skin syndrome.